New investors Fidelity Management & Research Company, Janus Henderson Investors and Blackstone Multi-Asset Investing join Series C syndicate led by Venrock Healthcare Capital Partners Tubulis announced
SimiTree, a provider of revenue cycle, coding, and consulting services for the post-acute and behavioral health industries, announced the launch of CLARITY, a real-time analytics
Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, announced a partnership with Manifold, the leading artificial intelligence (AI) data platform
Each year, more than 20 million diagnostic X-ray procedures are performed in Canada according to Health Canada. While regular X-rays are used every day in
Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research
Arya Health, an AI company helping home health and post-acute care providers automate scheduling, compliance, and other administrative operations, announced its $18.2 million Series A
Sparrow BioAcoustics has received a $10 million investment to help speed up the expansion of its Stethophone platform in hospitals across North America. The Stethophone
Church Health and the First Horizon Foundation have made a major announcement about a $2.5 million donation from the First Horizon Foundation. To celebrate this
Shanghai Ark Biopharmaceutical Co., Ltd., also referred to as ArkBio, has announced the start of a Phase II clinical trial for AK0610, a fully human
Piramal Pharma Solutions, a global leader in contract development and manufacturing and part of Piramal Pharma Ltd., has entered into a strategic partnership with IntoCell
Conexiant has introduced MDspire, a new AI-powered platform aimed at changing the way doctors, researchers, and healthcare professionals access and interact with clinical knowledge. The
Brenig Therapeutics, Inc., a clinical-stage company focused on developing innovative small-molecule therapies for neurodegenerative diseases and utilizing a proprietary AI-driven discovery platform, has appointed Megan
